J
Jasper Therapeutics (JSPR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Jasper Therapeutics (JSPR)
Jasper Therapeutics, Inc. is a biotechnology company focused on hematopoietic cell transplant therapies. The Company has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent t... Read more
- USD2.85
- USD3.03
- USD2.81
- USD26.05
- -18.80%
- --
- 164.09k
- 1.04M
- 37M
- 2.27
- -83.00%
Stock News
3 hours ago
Kodak's struggle for survival: The possible end of an icon?
Yahoo
6 hours ago
uCloudlink Group Inc. (UCL) Q2 2025 Earnings Call Transcript
SeekingAlpha
6 hours ago
10-Year U.S. Treasury Yield 'Fair Value' Estimate Steady In July
SeekingAlpha
6 hours ago
APLY: Extreme Yield ETF Based On Apple Options
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
